6 voices in 10 minutes: When do we choose SGLT2i or GLP1ag?

6 voices in 10 minutes: Strategies to reduce cardiovascular risk in patients with diabetes mellitus When do we choose SGLT2i or GLP1ag? In recent years, there has been a paradigm shift in diabetes’ aims of treatment, going from glycocentricity to assessment of mortality reduction and cardiovascular...

Full description

Bibliographic Details
Main Author: Cristina Faingold
Format: Article
Language:Spanish
Published: Sello Editorial Lugones 2020-11-01
Series:Revista de la Sociedad Argentina de Diabetes
Subjects:
Online Access:https://revistasad.com/index.php/diabetes/article/view/283